Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Treasury Shares: 2014-2023

Historic Treasury Shares for Viking Therapeutics (VKTX) over the last 2 years, with Dec 2023 value amounting to $6.8 million.

  • Viking Therapeutics' Treasury Shares changed negligibly% to $6.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was $6.8 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $6.8 million for FY2023, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q4 2023, Viking Therapeutics' Treasury Shares is $2.2 million, which was down 0.00% from $2.2 million recorded in Q3 2023.
  • Over the past 5 years, Viking Therapeutics' Treasury Shares peaked at $2.2 million during Q2 2022, and registered a low of $352,726 during Q4 2019.
  • Over the past 3 years, Viking Therapeutics' median Treasury Shares value was $2.2 million (recorded in 2023), while the average stood at $1.7 million.
  • Data for Viking Therapeutics' Treasury Shares shows a peak YoY surged of 32.69% (in 2023) over the last 5 years.
  • Viking Therapeutics' Treasury Shares (Quarterly) stood at $6.8 million in 2022, then remained steady at $6.8 million in 2023.
  • Its Treasury Shares was $6.8 million in Q4 2023, compared to $6.8 million in Q3 2023 and $6.8 million in Q2 2023.